Billing & Collection

Hospital Claims Review Resource Available

Livanta, Medicare’s national claims review contractor, has launched the Livanta Claims Review Advisor — a monthly online educational resource for medical coders, billing, financial and revenue cycle personnel, clinical documentation improvement specialists, utilization review coordinators, case managers, compliance officers, physicians, and other practitioners. 

CMS Releases Billing Codes for Johnson & Johnson, Moderna Booster Shots 

On Oct. 20, the Food and Drug Administration amended the emergency use authorization for COVID-19 vaccines to allow booster doses for the Moderna and Johnson & Johnson vaccines.   The Centers for Medicare & Medicaid Services has released new billing coding for the Johnson & Johnson and Moderna COVID-19 vaccine booster shots. Current billing codes, payment allowances, and effective dates are available online.  

CMS to Pay for COVID-19 Booster Shots

The Centers for Medicare & Medicaid Services has announced will pay the full cost of the Pfizer-BioNTech COVID-19 booster shots to providers without cost-sharing for Medicare, Medicaid, and the Children’s Health Insurance Program beneficiaries.  

FDA Announces Approval of Pfizer-BioNTech COVID-19 Vaccine

The Food and Drug Administration (FDA) today announced its full approval for the Pfizer-BioNTech COVID-19 vaccine — under the name Comirnaty — for individuals 16 and older, making it the first COVID-19 vaccine to go beyond emergency use authorization (EUA) in the U.S.  

Additional mRNA Vaccine Dose Authorized for ‘Moderately to Severely Immunocompromised’ Individuals

On Aug. 12, the Food and Drug Administration (FDA) expanded the emergency use authorization (EUA) for both the Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines to allow for the use of an additional dose in certain immunocompromised individuals ages 12 and older. Following that announcement, the Centers for Disease Control and Prevention issued a recommendation that […]

CDC Announces COVID-19 Vaccine Boosters for All, CMS Updates Coding Guidance

The Centers for Disease Control and Prevention (CDC) announced plans to begin offering COVID-19 booster shots to all individuals beginning the week of Sept. 20 and starting eight months after an individual’s second dose, pending authorization from the Food and Drug Administration (FDA) and a review by the CDC’s vaccine advisory committee.